Fda Alerts Article Listing | RxWiki

FDA Alerts

FDA Approves Companion Diagnostic to Detect Gene Mutation

The US Food and Drug Administration today approved the cobas EGFR Mutation Test, a companion diagnostic for the cancer drug Tarceva (erlotinib).

REFINE

medications
- - Remove Tarceva filter (-) Remove Tarceva filter Tarceva
conditions
- - Remove Cancer filter (-) Remove Cancer filter Cancer
    Remove Lung Cancer filter (-) Remove Lung Cancer filter Lung Cancer
    Remove Non Small Cell filter (-) Remove Non Small Cell filter Non Small Cell